FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Animal Drugs

Pancreatic Cancer Drug Gets Orphan Status

FDA awards PEP-Therapy an orphan drug designation for PEP-010 and its used for treating pancreatic cancer.

latest-news-card-1
Medical Devices

BD Alaris Pump Software Being Corrected

Becton, Dickinson corrects software for the BD Alaris Systems Manager and BD Care Coordination Engine Infusion Adapter after receiving reports that cu...

latest-news-card-1
Federal Register

FDA Revokes EUAs on 3 Beckman Coulter Tests

Federal Register notice: FDA revokes Emergency Use Authorizations issued to Beckman Coulter for three of its Access branded Covid-19 tests.

latest-news-card-1
Human Drugs

Aspen Pharmacare CGMP Violations

FDA warns South Africas Aspen Pharmacare about CGMP violations in its production of finished drugs as a contract manufacturing facility.

latest-news-card-1
Human Drugs

FDA Accepts Alvotech AVT03 BLA

FDA accepts a BLA submitted by Dr. Reddys and Alvotech for a biosimilar form of Amgens Prolia and Xgeva.

latest-news-card-1
Human Drugs

CGMP Violations at Canadas Vegewax Candleworx

FDA warns Concord, Ontario, Canada-based Vegewax Candleworx about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

Smiths Medical Recalls Venous Access System

Smiths Medical recalls its ProPort Plastic Venous Access System because the devices plastic port housing and port reservoir may separate.

latest-news-card-1
Human Drugs

2 ICH Guidelines Advance

The International Council for Harmonization says the M11 and M13B guidelines have advanced to the second public consultation.

latest-news-card-1
Federal Register

Device Consensus Standards Publication

Federal Register notice: FDA updates its publication on modifications to the list of recognized consensus standards for use in device premarket review...

latest-news-card-1
Human Drugs

Keytruda Full Approval for Gastroesophageal Cancer

FDA awards Merck traditional approval for Keytruda (pembrolizumab) for use in combination with trastuzumab and chemotherapy for the first-line treatme...